Probe | Locus(GRCh37) | Gene | Region | p-val | Trait | PubMed ID |
cg10538202 | chr7:154863338 | HTR5A | Promoter | 1.969e-5 | Alcohol use disorders | 26763658 |
cg03024742 | chr7:154863244 | HTR5A | Promoter | 2.706e-5 | Alcohol use disorders | 26763658 |
cg11298960 | chr7:154862548 | HTR5A | Promoter | 8.920e-5 | Alcohol use disorders | 26763658 |
cg20967585 | chr7:154862524 | HTR5A | Promoter | 3.716e-4 | Alcohol use disorders | 26763658 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
GABRG2 | 0.963 |
NELL2 | 0.959 |
FAXC | 0.959 |
RBFOX1 | 0.959 |
AMPH | 0.959 |
FBXL2 | 0.958 |
PCSK2 | 0.958 |
MAGEE1 | 0.957 |
SH3GL2 | 0.956 |
ATP2B3 | 0.956 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
RAI14 | -0.586 |
HEY2 | -0.585 |
YES1 | -0.584 |
FZD10 | -0.579 |
REST | -0.572 |
TFPI2 | -0.572 |
RNF135 | -0.564 |
WWTR1 | -0.561 |
MYL3 | -0.557 |
CSAG1 | -0.55 |
ID | Drug Name | Drug Type | CAS Num | Status | Role |
---|---|---|---|---|---|
DB00334 | Olanzapine | Small Molecule | 132539-06-1 | Approved|Investigational | Target |
DB00408 | Loxapine | Small Molecule | 1977-10-2 | Approved | Target |
DB06216 | Asenapine | Small Molecule | 65576-45-6 | Approved | Target |
ID | Drug Name | Action | PubMed |
---|---|---|---|
C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of HTR5A mRNA" | 25614096 |
C111118 | 2',3,3',4',5-pentachloro-4-hydroxybiphenyl | "2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of HTR5A mRNA" | 19114083 |
C008745 | 4,4'-bisphenol F | "4,4'-bisphenol F results in decreased expression of HTR5A mRNA" | 26186136 |
D000082 | Acetaminophen | Acetaminophen results in decreased expression of HTR5A mRNA | 26690555 |
D019386 | Alendronate | Alendronate affects the expression of HTR5A mRNA | 16079270 |
D000535 | Aluminum | [APP protein modified form binds to Aluminum] which results in decreased expression of HTR5A mRNA | 21298039 |
D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of HTR5A mRNA | 16483693 |
D003913 | Dextroamphetamine | Dextroamphetamine results in increased expression of HTR5A mRNA | 16715494 |
D017638 | Asbestos, Crocidolite | "Asbestos, Crocidolite results in increased expression of HTR5A mRNA" | 19446018 |
D001554 | Benzene | Benzene results in decreased expression of HTR5A mRNA | 21843810 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene promotes the reaction [AHR protein binds to HTR5A promoter] | 19654925 |
C006780 | bisphenol A | bisphenol A affects the expression of HTR5A mRNA | 23557687 |
C006780 | bisphenol A | bisphenol A results in decreased expression of HTR5A mRNA | 25181051 |
D001761 | Bleomycin | Bleomycin results in decreased expression of HTR5A mRNA | 15808516 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased methylation of HTR5A promoter | 22457795 |
D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased expression of HTR5A mRNA | 16644059 |
D004390 | Chlorpyrifos | Chlorpyrifos results in decreased expression of HTR5A mRNA | 17452286 |
D004390 | Chlorpyrifos | Chlorpyrifos results in increased expression of HTR5A mRNA | 18835401 |
D002994 | Clofibrate | Clofibrate results in decreased expression of HTR5A mRNA | 17585979 |
D003976 | Diazinon | Diazinon affects the expression of HTR5A mRNA | 17452286 |
D004026 | Dieldrin | Dieldrin results in increased expression of HTR5A mRNA | 18835401 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of HTR5A mRNA | 16079270 |
D005557 | Formaldehyde | Formaldehyde results in increased expression of HTR5A mRNA | 12679049 |
D019833 | Genistein | [Genistein co-treated with Methoxychlor] results in decreased expression of HTR5A mRNA | 21782745 |
D007854 | Lead | Lead affects the expression of HTR5A mRNA | 28903495 |
C008261 | lead acetate | lead acetate results in increased expression of HTR5A mRNA | 20542052 |
D008731 | Methoxychlor | [Genistein co-treated with Methoxychlor] results in decreased expression of HTR5A mRNA | 21782745 |
D020849 | Raloxifene Hydrochloride | Raloxifene Hydrochloride affects the expression of HTR5A mRNA | 16079270 |
C057693 | troglitazone | troglitazone results in increased expression of HTR5A mRNA | 28973697 |
D014635 | Valproic Acid | Valproic Acid results in increased methylation of HTR5A gene | 29154799 |
D019287 | Zinc Sulfate | Zinc Sulfate results in increased expression of HTR5A mRNA | 27504894 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0004930 | G-protein coupled receptor activity | - | IBA | 21873635 |
GO:0004993 | G-protein coupled serotonin receptor activity | - | IBA | 21873635 |
GO:0004993 | G-protein coupled serotonin receptor activity | - | IDA | 7988681 |
GO:0030594 | neurotransmitter receptor activity | - | IBA | 21873635 |
GO:0051378 | serotonin binding | - | IBA | 21873635 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0007186 | G-protein coupled receptor signaling pathway | - | TAS | - |
GO:0007187 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger | - | IBA | 21873635 |
GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway | - | IBA | 21873635 |
GO:0007268 | chemical synaptic transmission | - | IBA | 21873635 |
GO:0019933 | cAMP-mediated signaling | - | IEA | - |
GO:0021766 | hippocampus development | - | IEA | - |
GO:0032355 | response to estradiol | - | IEA | - |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0005791 | rough endoplasmic reticulum | - | IEA | - |
GO:0005794 | Golgi apparatus | - | IEA | - |
GO:0005886 | plasma membrane | - | TAS | - |
GO:0005887 | integral component of plasma membrane | - | IBA | 21873635 |
GO:0005887 | integral component of plasma membrane | - | IEA | - |
GO:0030425 | dendrite | - | IBA | 21873635 |
GO:0030425 | dendrite | - | IEA | - |
GO:0043204 | perikaryon | - | IEA | - |
Reactome ID | Reactome Term | Evidence |
---|---|---|
R-HSA-162582 | Signal Transduction | TAS |
R-HSA-372790 | Signaling by GPCR | TAS |
R-HSA-373076 | Class A/1 (Rhodopsin-like receptors) | TAS |
R-HSA-375280 | Amine ligand-binding receptors | TAS |
R-HSA-388396 | GPCR downstream signalling | TAS |
R-HSA-390666 | Serotonin receptors | TAS |
R-HSA-418594 | G alpha (i) signalling events | TAS |
R-HSA-500792 | GPCR ligand binding | TAS |
PMID | Title (Year) | Author | Journal |
---|---|---|---|
11134668 | Pharmacogenetics and the serotonin system: initial studies and future directions. (2000 Dec 27) | Veenstra-VanderWeele J | Eur J Pharmacol |